NCT06710847 2026-02-02
SYLVER
GlaxoSmithKline
Phase 1/2 Active not recruiting
GlaxoSmithKline
Bolt Biotherapeutics, Inc.
Maastricht University Medical Center
Chinese PLA General Hospital
Fujian Cancer Hospital
Medikine, Inc.
First Affiliated Hospital of Guangxi Medical University
Hunan Cancer Hospital